TrialScientific reports2021
The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab.
Bruno Carvalho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it
TrialScientific reports2021
Bruno Carvalho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.